118 related articles for article (PubMed ID: 22237674)
1. Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies.
Papathanasiou N; Rondogianni P; Chroni P; Themistocleous M; Boviatsis E; Pedeli X; Sakas D; Datseris I
Ann Nucl Med; 2012 Apr; 26(3):234-40. PubMed ID: 22237674
[TBL] [Abstract][Full Text] [Related]
2. Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies.
Söderlund TA; Dickson JC; Prvulovich E; Ben-Haim S; Kemp P; Booij J; Nobili F; Thomsen G; Sabri O; Koulibaly PM; Akdemir OU; Pagani M; van Laere K; Asenbaum-Nan S; George J; Sera T; Tatsch K; Bomanji J
J Nucl Med; 2013 May; 54(5):714-22. PubMed ID: 23492885
[TBL] [Abstract][Full Text] [Related]
3. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
4. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
[TBL] [Abstract][Full Text] [Related]
5. [Interobserver agreement in the visual and semi-quantitative analysis of the 123I-FP-CIT SPECT images in the diagnosis of Parkinsonian syndrome].
Suárez-Piñera M; Prat ML; Mestre-Fusco A; Fuertes J; Mojal S; Balaguer E
Rev Esp Med Nucl; 2011; 30(4):229-35. PubMed ID: 21524823
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
Buchert R; Hutton C; Lange C; Hoppe P; Makowski M; Bamousa T; Platsch G; Brenner W; Declerck J
Nucl Med Commun; 2016 May; 37(5):509-18. PubMed ID: 26703759
[TBL] [Abstract][Full Text] [Related]
7. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
8. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
[TBL] [Abstract][Full Text] [Related]
9. Interobserver reproducibility of the interpretation of I-123 FP-CIT single-photon emission computed tomography.
Tondeur MC; Hambye AS; Dethy S; Ham HR
Nucl Med Commun; 2010 Aug; 31(8):717-25. PubMed ID: 20614577
[TBL] [Abstract][Full Text] [Related]
10. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
11. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
[TBL] [Abstract][Full Text] [Related]
12. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using
Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B
Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935
[TBL] [Abstract][Full Text] [Related]
13. Does reduced [(123)I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?
Gamez J; Lorenzo-Bosquet C; Cuberas-Borrós G; Carmona F; Hernández-Vara J; Castilló J; Castell-Conesa J
Clin Neurol Neurosurg; 2010 Dec; 112(10):870-5. PubMed ID: 20724066
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
[TBL] [Abstract][Full Text] [Related]
15. Validation of an automated morphological MRI-based (123)I-FP-CIT SPECT evaluation method.
Perlaki G; Szekeres S; Orsi G; Papp L; Suha B; Nagy SA; Doczi T; Janszky J; Zambo K; Kovacs N
Parkinsonism Relat Disord; 2016 Aug; 29():24-9. PubMed ID: 27290659
[TBL] [Abstract][Full Text] [Related]
16. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
Jauković L; Ilić TV; Dopudja M; Ajdinović B
Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
[TBL] [Abstract][Full Text] [Related]
17. Combined visual and semi-quantitative assessment of
Ueda J; Yoshimura H; Shimizu K; Hino M; Kohara N
Neurol Sci; 2017 Jul; 38(7):1187-1191. PubMed ID: 28389938
[TBL] [Abstract][Full Text] [Related]
18. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
Hauser RA; Grosset DG
J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
[TBL] [Abstract][Full Text] [Related]
19. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
[TBL] [Abstract][Full Text] [Related]
20. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
Koch W; Radau PE; Hamann C; Tatsch K
J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
